Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 19, 2023 09:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting

NEWTOWN, Pa., April 19, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and...
March 16, 2023 16:04 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update

NEWTOWN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
September 22, 2022 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference

NEWTOWN, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
August 11, 2022 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

NEWTOWN, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
May 26, 2022 17:10 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Abstract at the ASCO Annual Meeting Highlighting Narazaciclib’s Differentiated Inhibitory and Improved Safety Profile in Preclinical Models

NEWTOWN, Pa., May 26, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
May 11, 2022 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

NEWTOWN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
May 04, 2022 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce First Quarter Financial Results on May 11, 2022

NEWTOWN, Pa., May 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
April 27, 2022 10:17 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Acceptance of Abstract for Publication at the ASCO Annual Meeting

NEWTOWN, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
March 23, 2022 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at the Next Generation Kinase Inhibitors Summit

NEWTOWN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
November 22, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

NEWTOWN, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...

Next Page keyboard_arrow_right